Waldenström's macroglobulinemia epidemiology and demographics: Difference between revisions
Line 12: | Line 12: | ||
NCBI (2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436227/ Accessed on November, 6 2015</ref> | NCBI (2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436227/ Accessed on November, 6 2015</ref> | ||
REFERENCES: | |||
{{Reflist}} |
Revision as of 19:49, 6 November 2015
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia epidemiology and demographics |
FDA on Waldenström's macroglobulinemia epidemiology and demographics |
CDC on Waldenström's macroglobulinemia epidemiology and demographics |
Waldenström's macroglobulinemia epidemiology and demographics in the news |
Blogs on Waldenström's macroglobulinemia epidemiology and demographics |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
The prevalence of Waldenström's macroglobulinemia is estimated to be 1500 cases in United States annually.[1]
Waldenström's macroglobulinemia represents 1% of all hematological cancers.[2]
REFERENCES:
- ↑ Waldenström’s macroglobulinemia Wikipedia (2015) https://en.wikipedia.org/wiki/Waldenström%27s_macroglobulinemia#cite_note-Cheson-1 Accessed on November, 6 2015
- ↑ Molecular pathogenesis of Waldenström’s macroglobulinemia NCBI (2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436227/ Accessed on November, 6 2015